Transparency of COVID-19 vaccine trials: decisions without dataSarah Tanveer, Anisa Rowhani-Farid, Kyungwan Hong, Tom Jefferson, Peter Doshi
9 August 2021
Misleading clinical evidence and systematic reviews on ivermectin for COVID-19Luis Ignacio Garegnani, Eva Madrid, Nicolás Meza
22 April 2021
Characteristics, quality and volume of the first 5 months of the COVID-19 evidence synthesis infodemic: a meta-research studyRebecca Abbott, Alison Bethel, Morwenna Rogers, Rebecca Whear, Noreen Orr, Liz Shaw, Ken Stein, Jo Thompson Coon
3 June 2021
Evidence on the efficacy of ivermectin for COVID-19: another story of apples and orangesMaria Popp, Peter Kranke, Patrick Meybohm, Maria-Inti Metzendorf, Nicole Skoetz, Miriam S Stegemann, Stephanie Weibel
20 August 2021
Getting the COVID-19 vaccine as a transplant patientMichael Mittelman
8 June 2021
Can shared decision making address COVID-19 vaccine hesitancy?Marie-Anne Durand, Peter Scalia, Glyn Elwyn
26 April 2021
Publication by association: how the COVID-19 pandemic has shown relationships between authors and editorial board members in the field of infectious diseasesClara Locher, David Moher, Ioana Alina Cristea, Florian Naudet
30 March 2021
COVID-19 information in news media: room for greater transparencyAnisa Rowhani-Farid, Kyungwan Hong
25 February 2021
SARS-CoV-2 myocarditis: what physicians need to knowArsalan Khalil, Tamara Naneishvili, Neeraj Prasad, James Glancy
5 January 2021
Evaluating the performance of high-sensitivity troponin-T in the emergency department during the COVID-19 pandemicAli A Alsaad, Ernest Wang, Hong Lee, Mark Lampert, Philip Krause, Carl Tommaso, Gregory Mishkel, John Erwin, Christopher Boyle, Sarah Donlan, Jeremy Smiley, Mahalakshmi Halasyamani
23 September 2020